医麦客新闻 eMedClub News
近日,Altamira Therapeutics宣布与Univercells Group达成合作协议,以评估该公司专有的、基于肽的SemaPhore平台在mRNA疫苗递送方面的应用,SemaPhore平台有望代替LNP递送系统,在mRNA领域中有广泛地应用潜力。如果实验成功,Univercells和Altam...查看全文
医麦客03-28 10:35
2024年3月28日
医麦客新闻 eMedClub News
近日,Altamira Therapeutics宣布与Univercells Group达成合作协议,以评估该公司专有的、基于肽的SemaPhore平台在mRNA疫苗递送方面的应用,SemaPhore平台有望代替LNP递送系统,在mRNA领域中有广泛地应用潜力。如果实验成功,Univercells和Altam...查看全文
F1watch2023-07-05 18:20
F-1/A - Altamira Therapeutics Ltd. (0001601936) (Filer) Filed: 2023-07-05 AccNo: 0001213900-23-054243 Size: 1 MB 网页链接查看全文
F1watch2023-06-17 05:20
F-1 - Altamira Therapeutics Ltd. (0001601936) (Filer) Filed: 2023-06-16 AccNo: 0001213900-23-049716 Size: 500 KB 网页链接查看全文
稳妥的回报将军2023-06-16 09:18
上周多伦多证券交易所创业板(TSXV)涨幅最大的资源股是Solis Minerals、MacArthur Minerals、Altamira Gol、VR Resources和Tier One Silver。虽然大盘The S&P/TSX Venture Composite Index (INDEXTSI:JX)上周保持平稳,周五(6月9日)收于610.02点,但领涨的一只资源股的股价在短短五个交易日...查看全文
F1watch2023-06-02 04:40
F-1 - Altamira Therapeutics Ltd. (0001601936) (Filer) Filed: 2023-06-01 AccNo: 0001213900-23-045058 Size: 351 KB 网页链接查看全文
医麦客2023-04-15 07:36
2023年4月15日/医麦客新闻 eMedClub News/--mRNA疫苗技术已发展数十年,研究历史可追溯至20世纪60年代,近两年来疫情的爆发及大流行大大加快了mRNA技术的成熟。目前上市的mRNA产品仅新冠疫苗一类,其他产品仍在临床开发中。近年来的临床研究已表明,mRNA疫苗在疾病预防和肿瘤治疗等多个领域具有巨...查看全文
F1watch2023-03-27 22:40
F-1/A - Altamira Therapeutics Ltd. (0001601936) (Filer) Filed: 2023-03-27 AccNo: 0001213900-23-023002 Size: 15 MB 网页链接查看全文
F1watch2023-03-13 21:20
F-1/A - Altamira Therapeutics Ltd. (0001601936) (Filer) Filed: 2023-03-13 AccNo: 0001213900-23-019406 Size: 15 MB 网页链接查看全文
F1watch2023-03-02 02:10
F-1/A - Altamira Therapeutics Ltd. (0001601936) (Filer) Filed: 2023-03-01 AccNo: 0001213900-23-016044 Size: 15 MB 网页链接查看全文
$Auris Medical(EARS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-021259 Act: 34 Size: 59 KB 网页链接
$Auris Medical(EARS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-018970 Act: 34 Size: 153 KB 网页链接
$Auris Medical(EARS)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001213900-21-018959 Act: 34 Size: 9 MB 网页链接
$Auris Medical(EARS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-015009 Act: 34 Size: 19 KB 网页链接
$Auris Medical(EARS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001387131-21-002303 Act: 34 Size: 128 KB 网页链接
$Auris Medical(EARS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-21-002561 Act: 34 Size: 43 KB 网页链接
$Auris Medical(EARS)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001213900-21-002553 Act: 33 Size: 507 KB 网页链接
$Auris Medical(EARS)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001213900-21-002526 Act: 33 Size: 99 KB 网页链接
$Auris Medical(EARS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-20-041928 Act: 34 Size: 14 KB 网页链接
$Auris Medical(EARS)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001213900-20-041297 Act: 34 Size: 44 KB 网页链接